Nagoya, Japan

Mitsutaka Kanamaru


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mitsutaka Kanamaru: Innovator in Pharmaceutical Composition

Introduction

Mitsutaka Kanamaru is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating various medical conditions. With a total of 2 patents to his name, Kanamaru's work has the potential to impact many lives.

Latest Patents

Kanamaru's latest patents include a diuretic or antihypertensive composition. This invention provides a method for treating edema or hypertension by administering an effective amount of a quinazoline derivative. The specific formula involves R.sup.1, R.sup.2, and R.sup.3, which can be hydrogen atoms, halogen atoms, or pharmaceutically acceptable salts. Another significant patent is a uricosuric composition aimed at preventing and treating gout and hyperuricemia. This method also utilizes a quinazoline derivative of a similar general formula to provide effective treatment.

Career Highlights

Mitsutaka Kanamaru is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been able to apply his innovative ideas in a professional setting. His work at this esteemed company has allowed him to focus on developing effective pharmaceutical solutions.

Collaborations

Kanamaru has collaborated with notable coworkers, including Mitsuyoshi Nakashima and Akira Sugiyama. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mitsutaka Kanamaru is a distinguished inventor whose work in pharmaceutical compositions demonstrates his commitment to improving healthcare. His innovative patents reflect his expertise and dedication to addressing critical medical issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…